AHA yesterday submitted comment to the Centers for Medicare & Medicaid Services on the agency’s proposed skilled nursing facility prospective payment system for fiscal year 2021, urging CMS to support additional funds to offset the cost of critically important COVID-19 testing.

AHA said COVID-19-positive patients “are widely acknowledged to generally require substantial additional clinical and other resources… While a portion of these costs have been supported with much-appreciated emergency funds, COVID-19 testing remains a particularly costly ongoing need, with the added expectation that it will resurface during future pandemics.”

Also, AHA agreed it was appropriate for CMS to exclude selected data from the SNF value-based purchasing program, to recognize the impact of the pandemic. Read AHA’s full comments.

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…